Lv1
20 积分 2023-02-16 加入
Molecular Alterations and Comprehensive Clinical Management of Oncocytic Thyroid Carcinoma
1天前
已完结
Molecular Alterations and Comprehensive Clinical Management of Oncocytic Thyroid Carcinoma
1天前
已完结
Cyclin-Dependent Kinase 4/6 Inhibition as a Novel Therapy for Peritoneal Mucinous Carcinomatosis With GNAS Mutations
5天前
已完结
Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial
24天前
已完结
Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With RAS/BRAF Wild-Type, HER2-Positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase II Trial
24天前
已完结
FURVENT: Phase 3 trial of firmonertinib vs chemotherapy as first-line treatment for advanced NSCLC with EGFR exon 20 insertion mutations (FURMO-004)
27天前
已完结
A method of high-throughput functional evaluation of EGFR gene variants of unknown significance in cancer
28天前
已完结
Recent advances of antibody-drug conjugates in treating breast cancer with different HER2 status
29天前
已完结
Genebe.net: Implementation and validation of an automatic ACMG variant pathogenicity criteria assignment
1个月前
已完结
皖公网安备34019202002308
